The UK Study That Found 92% of Combination Therapy Patients Improved: Full Analysis

A 2025 UK real-world study of 502 patients is the largest real-world confirmation of combination hair loss therapy to date — and its headline number is striking: 92% of patients on finasteride plus minoxidil combination showed improvement. Here's what the study showed and why it matters.

01Study details

The study followed 502 patients (predominantly male, ages 18–65) at UK NHS hair clinics on combination oral finasteride 1mg and topical minoxidil 5% for 12 months. Primary outcome: hair density measured by trichoscopy at baseline, 6 months, and 12 months. Secondary outcome: patient-reported satisfaction and quality of life scores.

02Why real-world data matters differently

Clinical trials control who participates, how consistently they take medication, and how outcomes are measured. Real-world studies capture what happens when actual patients, with varying adherence and backgrounds, use these treatments in normal clinical settings. A 92% improvement rate in that context is more conservative and more realistic than trial conditions would produce — which makes it more useful for predicting your actual experience.

03The adherence factor

The study also analyzed adherence: patients who missed doses consistently showed significantly lower improvement rates. The drug isn't the only variable — taking it every day is. This is the real-world version of the clinical finding that finasteride + minoxidil works best when both components are used consistently over the full 12 months.